Skip to main content
Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.310
-0.080 (-5.76%)
At close: Apr 1, 2025, 4:00 PM
1.320
+0.009 (0.73%)
After-hours: Apr 1, 2025, 4:34 PM EDT

Enveric Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Selling, General & Admin
6.458.9711.7319.885.32
Upgrade
Research & Development
2.847.147.914.760.17
Upgrade
Operating Expenses
9.6316.4519.9625.295.62
Upgrade
Operating Income
-9.63-16.45-19.96-25.29-5.62
Upgrade
Interest Expense
---0.01-0.01-0.45
Upgrade
Interest & Investment Income
00---
Upgrade
Other Non Operating Income (Expenses)
0.07-0.827.468.2-0.8
Upgrade
EBT Excluding Unusual Items
-9.57-17.26-12.5-17.1-6.86
Upgrade
Merger & Restructuring Charges
----0.65-
Upgrade
Impairment of Goodwill
---1.49-8.23-
Upgrade
Asset Writedown
---5.97-30.45-
Upgrade
Pretax Income
-9.57-17.26-19.96-56.43-6.86
Upgrade
Income Tax Expense
0.010.03-1.49-7.45-
Upgrade
Net Income
-9.57-17.29-18.47-48.98-6.86
Upgrade
Preferred Dividends & Other Adjustments
-0.170.33--
Upgrade
Net Income to Common
-9.57-17.46-18.8-48.98-6.86
Upgrade
Shares Outstanding (Basic)
1000-
Upgrade
Shares Outstanding (Diluted)
1000-
Upgrade
Shares Change (YoY)
249.39%49.31%206.13%--
Upgrade
EPS (Basic)
-19.04-121.29-195.02-1555.32-
Upgrade
EPS (Diluted)
-19.04-121.29-195.02-1555.32-
Upgrade
Free Cash Flow
-7.73-14.1-17.73-11.65-3.89
Upgrade
Free Cash Flow Per Share
-15.36-97.96-183.93-369.88-
Upgrade
EBITDA
-9.29-16.1-19.63-24.64-5.5
Upgrade
D&A For EBITDA
0.340.340.330.660.12
Upgrade
EBIT
-9.63-16.45-19.96-25.29-5.62
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q